{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:20:01Z","timestamp":1793834401618,"version":"4.6.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2016002"],"award-info":[{"award-number":["2016002"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Neurocognitive disorder (NCD) is common in stroke survivors. We aimed to identify clinically accessible imaging markers of stroke and chronic pathology that are associated with early post-stroke NCD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included 231 stroke survivors from the \u201cNorwegian Cognitive Impairment after Stroke (Nor-COAST)\u201d study who underwent a standardized cognitive assessment 3 months after the stroke. Any NCD (mild cognitive impairment and dementia) and major NCD (dementia) were diagnosed according to \u201cDiagnostic and Statistical Manual of Mental Disorders (DSM-5)\u201d criteria. Clinically accessible imaging findings were analyzed on study-specific brain MRIs in the early phase after stroke. Stroke lesion volumes were semi automatically quantified and strategic stroke locations were determined by an atlas based coregistration. White matter hyperintensities (WMH) and medial temporal lobe atrophy (MTA) were visually scored. Logistic regression was used to identify neuroimaging findings associated with major NCD and any NCD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean age was 71.8\u2009years (SD 11.1), 101 (43.7%) were females, mean time from stroke to imaging was 8 (SD 16) days. At 3 months 63 (27.3%) had mild NCD and 65 (28.1%) had major NCD. Any NCD was significantly associated with WMH pathology (odds ratio (OR)\u2009=\u20092.73 [1.56 to 4.77],<jats:italic>p<\/jats:italic>\u2009=\u20090.001), MTA pathology (OR\u2009=\u20091.95 [1.12 to 3.41],<jats:italic>p<\/jats:italic>\u2009=\u20090.019), and left hemispheric stroke (OR\u2009=\u20091.8 [1.05 to 3.09],<jats:italic>p<\/jats:italic>\u2009=\u20090.032). Major NCD was significantly associated with WMH pathology (OR\u2009=\u20092.54 [1.33 to 4.84],<jats:italic>p<\/jats:italic>\u2009=\u20090.005) and stroke lesion volume (OR (per ml) =1.04 [1.01 to 1.06],<jats:italic>p<\/jats:italic>\u2009=\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>WMH pathology, MTA pathology and left hemispheric stroke were associated with the development of any NCD. Stroke lesion volume and WMH pathology were associated with the development of major NCD 3 months after stroke. These imaging findings may be used in the routine clinical setting to identify patients at risk for early post-stroke NCD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>ClinicalTrials.gov,<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02650531\">NCT02650531<\/jats:ext-link>, Registered 8 January 2016 \u2013 Retrospectively registered.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12883-021-02117-8","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T05:40:09Z","timestamp":1614231609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinically accessible neuroimaging predictors of post-stroke neurocognitive disorder: a prospective observational study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5336-0515","authenticated-orcid":false,"given":"Till","family":"Schellhorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Birgitte","family":"Aamodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stian","family":"Lydersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina","family":"Aam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torgeir Bruun","family":"Wyller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Saltvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Kristiansen","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"issue":"9","key":"2117_CR1","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/ene.12743","volume":"22","author":"H Jokinen","year":"2015","unstructured":"Jokinen H, Melkas S, Ylikoski R, Pohjasvaara T, Kaste M, Erkinjuntti T, et al. Post-stroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015;22(9):1288\u201394.","journal-title":"Eur J Neurol"},{"issue":"3","key":"2117_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1474-4422(18)30442-3","volume":"18","author":"ST Pendlebury","year":"2019","unstructured":"Pendlebury ST, Rothwell PM. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford vascular study. Lancet Neurol. 2019;18(3):248\u201358.","journal-title":"Lancet Neurol"},{"issue":"5","key":"2117_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1212\/01.WNL.0000152984.28420.5A","volume":"64","author":"GMS Nys","year":"2005","unstructured":"Nys GMS, van Zandvoort MJE, de Kort PLM, van der Worp HB, Jansen BPW, Algra A, et al. The prognostic value of domain-specific cognitive abilities in acute first-ever stroke. Neurology. 2005;64(5):821.","journal-title":"Neurology."},{"issue":"11","key":"2117_CR4","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1136\/jnnp.2009.174573","volume":"80","author":"NK Oksala","year":"2009","unstructured":"Oksala NK, Jokinen H, Melkas S, Oksala A, Pohjasvaara T, Hietanen M, et al. Cognitive impairment predicts poststroke death in long-term follow-up. J Neurol Neurosurg Psychiatry. 2009;80(11):1230\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2117_CR5","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, editor. Diagnostic and Statistical Manual of Mental Disorders. 5th ed: American Psychiatric Association; 2013. [cited 2020 Jun 15]. Available from: http:\/\/psychiatryonline.org\/doi\/book\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"11","key":"2117_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrneurol.2014.181","volume":"10","author":"PS Sachdev","year":"2014","unstructured":"Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol. 2014;10(11):634\u201342.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2117_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12883-015-0288-2","volume":"15","author":"L Mellon","year":"2015","unstructured":"Mellon L, Brewer L, Hall P, Horgan F, Williams D, Hickey A, et al. Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study. BMC Neurol. 2015;15(1):31.","journal-title":"BMC Neurol"},{"issue":"1","key":"2117_CR8","doi-asserted-by":"crossref","first-page":"e12000","DOI":"10.1002\/trc2.12000","volume":"6","author":"R Munthe-Kaas","year":"2020","unstructured":"Munthe-Kaas R, Aam S, Ihle-Hansen H, Lydersen S, Knapskog A-B, Wyller TB, et al. Impact of different methods defining post-stroke neurocognitive disorder: the nor-COAST study. Alzheimers Dement. 2020;6(1):e12000.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2117_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/STROKEAHA.119.026170","volume":"51","author":"H Jokinen","year":"2020","unstructured":"Jokinen H, Koikkalainen J, Laakso HM, Melkas S, Nieminen T, Brander A, et al. Global burden of small vessel disease\u2013related brain changes on MRI predicts cognitive and functional decline. Stroke. 2020;51(1):170\u20138.","journal-title":"Stroke."},{"issue":"7","key":"2117_CR10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1747-4949.2012.00837.x","volume":"7","author":"ST Pendlebury","year":"2012","unstructured":"Pendlebury ST. Dementia in patients hospitalized with stroke: rates, time course, and Clinico-pathologic factors. Int J Stroke. 2012;7(7):570\u201381.","journal-title":"Int J Stroke"},{"issue":"6","key":"2117_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11910-012-0315-2","volume":"12","author":"R Grysiewicz","year":"2012","unstructured":"Grysiewicz R, Gorelick PB. Key neuroanatomical structures for post-stroke cognitive impairment. Curr Neurol Neurosci Rep. 2012;12(6):703\u20138.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"2117_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.mayocp.2020.01.027","volume":"95","author":"MD Schirmer","year":"2020","unstructured":"Schirmer MD, Donahue KL, Nardin MJ, Dalca AV, Giese A-K, Etherton MR, et al. Brain volume: an important determinant of functional outcome after acute ischemic stroke. Mayo Clin Proc. 2020;95(5):955\u201365.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2117_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0022-510X(70)90063-8","volume":"11","author":"BE Tomlinson","year":"1970","unstructured":"Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci. 1970;11(3):205\u201342.","journal-title":"J Neurol Sci"},{"issue":"11","key":"2117_CR14","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1161\/STROKEAHA.118.021981","volume":"49","author":"L Puy","year":"2018","unstructured":"Puy L, Barbay M, Roussel M, Canaple S, Lamy C, Arnoux A, et al. Neuroimaging determinants of Poststroke cognitive performance. Stroke. 2018;49(11):2666\u201373.","journal-title":"Stroke."},{"issue":"3","key":"2117_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/1747493016676612","volume":"12","author":"L Sivakumar","year":"2017","unstructured":"Sivakumar L, Riaz P, Kate M, Jeerakathil T, Beaulieu C, Buck B, et al. White matter hyperintensity volume predicts persistent cognitive impairment in transient ischemic attack and minor stroke. Int J Stroke. 2017;12(3):264\u201372.","journal-title":"Int J Stroke"},{"issue":"3","key":"2117_CR16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3233\/JAD-190339","volume":"70","author":"J Molad","year":"2019","unstructured":"Molad J, Hallevi H, Korczyn AD, Kliper E, Auriel E, Bornstein NM, et al. Vascular and neurodegenerative markers for the prediction of post-stroke cognitive impairment: results from the TABASCO study. J Alzheimers Dis. 2019;70(3):889\u201398.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"2117_CR17","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1161\/01.STR.31.11.2597","volume":"31","author":"VN Thijs","year":"2000","unstructured":"Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome?: a multivariable analysis. Stroke. 2000;31(11):2597\u2013602.","journal-title":"Stroke."},{"issue":"1","key":"2117_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12883-018-1198-x","volume":"18","author":"P Thingstad","year":"2018","unstructured":"Thingstad P, Askim T, Beyer MK, Braathen G, Ellekj\u00e6r H, Ihle-Hansen H, et al. The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study. BMC Neurol. 2018;18(1):193.","journal-title":"BMC Neurol"},{"issue":"5","key":"2117_CR19","first-page":"541","volume":"54","author":"S Hatano","year":"1976","unstructured":"Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541\u201353.","journal-title":"Bull World Health Organ"},{"key":"2117_CR20","first-page":"1","volume":"14","author":"T Schellhorn","year":"2020","unstructured":"Schellhorn T, Zucknick M, Askim T, Munthe-Kaas R, Ihle-Hansen H, Seljeseth YM, et al. Vascular brain pathology is more important than neurodegeneration in the pathogenesis of pre-stroke cognitive impairment. medRxiv. 2020;14:1.","journal-title":"medRxiv"},{"issue":"Supplement 1","key":"2117_CR21","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/j.neuroimage.2008.10.055","volume":"45","author":"MW Woolrich","year":"2009","unstructured":"Woolrich MW, Jbabdi S, Patenaude B, Chappell M, Makni S, Behrens T, et al. Bayesian analysis of neuroimaging data in FSL. NeuroImage. 2009;45(Supplement 1):S173\u201386.","journal-title":"NeuroImage"},{"issue":"2","key":"2117_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","volume":"5","author":"M Jenkinson","year":"2001","unstructured":"Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001;5(2):143\u201356.","journal-title":"Med Image Anal"},{"issue":"3","key":"2117_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116\u201328.","journal-title":"Neuroimage."},{"issue":"1","key":"2117_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/STROKEAHA.115.011242","volume":"47","author":"F Munsch","year":"2016","unstructured":"Munsch F, Sagnier S, Asselineau J, Bigourdan A, Guttmann CR, Debruxelles S, et al. Stroke location is an independent predictor of cognitive outcome. Stroke. 2016;47(1):66\u201373.","journal-title":"Stroke."},{"issue":"8","key":"2117_CR25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1177\/0271678X17728162","volume":"38","author":"L Zhao","year":"2018","unstructured":"Zhao L, Biesbroek JM, Shi L, Liu W, Kuijf HJ, Chu WW, et al. Strategic infarct location for post-stroke cognitive impairment: a multivariate lesion-symptom mapping study. J Cereb Blood Flow Metab. 2018;38(8):1299\u2013311.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"2117_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","volume":"10","author":"JL Lancaster","year":"2000","unstructured":"Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 2000;10(3):120\u201331.","journal-title":"Hum Brain Mapp"},{"issue":"34","key":"2117_CR27","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.21105\/joss.01257","volume":"4","author":"M Notter","year":"2019","unstructured":"Notter M, Gale D, Herholz P, Markello R, Notter-Bielser M-L, Whitaker K. AtlasReader: a Python package to generate coordinate tables, region labels, and informative figures from statistical MRI images. J Open Source Softw. 2019;4(34):1257.","journal-title":"J Open Source Softw"},{"issue":"2","key":"2117_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351\u20136.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2117_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nic.2011.11.007","volume":"22","author":"MW Vernooij","year":"2012","unstructured":"Vernooij MW, Smits M. Structural neuroimaging in aging and Alzheimer\u2019s disease. Neuroimaging Clin N Am. 2012;22(1):33\u201355.","journal-title":"Neuroimaging Clin N Am"},{"issue":"10","key":"2117_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in probable Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2117_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/joim.12358","volume":"278","author":"D Ferreira","year":"2015","unstructured":"Ferreira D, Cavallin L, Larsson E-M, Muehlboeck J-S, Mecocci P, Vellas B, et al. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer\u2019s disease and mild cognitive impairment. J Intern Med. 2015;278(3):277\u201390.","journal-title":"J Intern Med"},{"issue":"1","key":"2117_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams","year":"1993","unstructured":"Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35\u201341.","journal-title":"Stroke."},{"issue":"9","key":"2117_CR33","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","volume":"139","author":"B Reisberg","year":"1982","unstructured":"Reisberg B, Ferris S, de Leon M, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatr. 1982;139(9):1136\u20139.","journal-title":"Am J Psychiatr"},{"issue":"4","key":"2117_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"2117_CR35","volume-title":"Stata. tata Statistical Software: Release 16","author":"StataCorp","year":"2019","unstructured":"StataCorp. Stata. tata Statistical Software: Release 16. College Station: StataCorp LLC; 2019."},{"issue":"11","key":"2117_CR36","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.neurobiolaging.2006.07.009","volume":"28","author":"MJ Firbank","year":"2007","unstructured":"Firbank MJ, Burton EJ, Barber R, Stephens S, Kenny RA, Ballard C, et al. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging. 2007;28(11):1664\u20139.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"2117_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.47830\/jinma-vol.70.8-2020-201","volume":"70","author":"S Dienanta","year":"2020","unstructured":"Dienanta S, Hamdan M, Soetjipto S, Machin A. The relevance of right and left hemisphere classification to predict cognitive outcome after stroke. J Indonesian Med Assoc. 2020 Sep 3;70(8):151\u20138.","journal-title":"J Indonesian Med Assoc"},{"issue":"5","key":"2117_CR38","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.01.010","volume":"28","author":"S Sagnier","year":"2019","unstructured":"Sagnier S, Munsch F, Bigourdan A, Debruxelles S, Poli M, Renou P, et al. The influence of stroke location on cognitive and mood impairment. A voxel-based lesion-symptom mapping study. J Stroke Cerebrovasc Dis. 2019;28(5):1236\u201342.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"11","key":"2117_CR39","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","volume":"8","author":"ST Pendlebury","year":"2009","unstructured":"Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006\u201318.","journal-title":"Lancet Neurol"},{"issue":"5","key":"2117_CR40","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/STROKEAHA.116.015156","volume":"48","author":"B Amber","year":"2017","unstructured":"Amber B, Boers AM, Bot Joseph CJ, Berkhemer OA, Lingsma HF, Yoo AJ, et al. Associations of ischemic lesion volume with functional outcome in patients with acute ischemic stroke. Stroke. 2017;48(5):1233\u201340.","journal-title":"Stroke."},{"issue":"5","key":"2117_CR41","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/STROKEAHA.111.646570","volume":"43","author":"V Gerhard","year":"2012","unstructured":"Gerhard V, Rico L, Ashfaq S, Armin S. Initial lesion volume is an independent predictor of clinical stroke outcome at day 90. Stroke. 2012;43(5):1266\u201372.","journal-title":"Stroke."},{"issue":"12","key":"2117_CR42","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1161\/STROKEAHA.112.671594","volume":"43","author":"SF Zaidi","year":"2012","unstructured":"Zaidi SF, Amin A, Xabier U, Mouhammada J, Brian J, Maxim H, et al. Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy. Stroke. 2012;43(12):3238\u201344.","journal-title":"Stroke."},{"issue":"6","key":"2117_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/neurintsurg-2015-011731","volume":"8","author":"L Elijovich","year":"2016","unstructured":"Elijovich L, Goyal N, Mainali S, Hoit D, Arthur AS, Whitehead M, et al. CTA collateral score predicts infarct volume and clinical outcome after endovascular therapy for acute ischemic stroke: a retrospective chart review. J NeuroIntervent Surg. 2016;8(6):559\u201362.","journal-title":"J NeuroIntervent Surg"},{"issue":"4","key":"2117_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3174\/ajnr.A6478","volume":"41","author":"EA Mistry","year":"2020","unstructured":"Mistry EA, Mistry AM, Mehta T, Arora N, Starosciak AK, Rosa FDLRL, et al. White matter disease and outcomes of mechanical Thrombectomy for acute ischemic stroke. Am J Neuroradiol. 2020;41(4):639\u201344.","journal-title":"Am J Neuroradiol"},{"issue":"1","key":"2117_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2014.07.019","volume":"36","author":"AM Brickman","year":"2015","unstructured":"Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, et al. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer\u2019s disease incidence. Neurobiol Aging. 2015;36(1):27\u201332.","journal-title":"Neurobiol Aging"},{"key":"2117_CR46","doi-asserted-by":"publisher","first-page":"c3666","DOI":"10.1136\/bmj.c3666","volume":"341","author":"S Debette","year":"2010","unstructured":"Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (Clinical research ed). 2010;341:c3666.","journal-title":"BMJ (Clinical research ed)"},{"issue":"9","key":"2117_CR47","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia. Stroke. 2011;42(9):2672\u2013713.","journal-title":"Stroke."},{"issue":"11","key":"2117_CR48","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/JGP.0b013e3181b208ef","volume":"17","author":"AP Haley","year":"2009","unstructured":"Haley AP, Hoth KF, Gunstad J, Paul RH, Jefferson AL, Tate DF, et al. Subjective cognitive complaints relate to white matter Hyperintensities and future cognitive decline in patients with cardiovascular disease. Am J Geriatr Psychiatry. 2009;17(11):976\u201385.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"2117_CR49","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1161\/STROKEAHA.109.570044","volume":"41","author":"S Debette","year":"2010","unstructured":"Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality. Stroke. 2010;41(4):600\u20136.","journal-title":"Stroke."},{"issue":"8","key":"2117_CR50","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013 Aug;12(8):822\u201338.","journal-title":"Lancet Neurol"},{"issue":"1","key":"2117_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/01.STR.0000149625.99732.69","volume":"36","author":"WT Longstreth","year":"2005","unstructured":"Longstreth WT, Arnold AM, Beauchamp NJ, Manolio TA. Lefkowitz David, Jungreis Charles, et al. incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly. Stroke. 2005;36(1):56\u201361.","journal-title":"Stroke."},{"issue":"13","key":"2117_CR52","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa022066","volume":"348","author":"SE Vermeer","year":"2003","unstructured":"Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215\u201322.","journal-title":"N Engl J Med"},{"issue":"3","key":"2117_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11(3):157\u201365.","journal-title":"Nat Rev Neurol"},{"issue":"6512","key":"2117_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abb8739","volume":"370","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science. 2020;370(6512):50\u20136.","journal-title":"Science."},{"issue":"32","key":"2117_CR55","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1523\/JNEUROSCI.1974-18.2019","volume":"39","author":"KN Mortensen","year":"2019","unstructured":"Mortensen KN, Sanggaard S, Mestre H, Lee H, Kostrikov S, Xavier ALR, et al. Impaired Glymphatic transport in spontaneously hypertensive rats. J Neurosci. 2019;39(32):6365\u201377.","journal-title":"J Neurosci"},{"issue":"2","key":"2117_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol. 2010;6(2):67\u201377.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"2117_CR57","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/ene.12376","volume":"21","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Ye BS, Yoon CW, Noh Y, Kim GH, Cho H, et al. Cortical thickness and hippocampal shape in pure vascular mild cognitive impairment and dementia of subcortical type. Eur J Neurol. 2014;21(5):744\u201351.","journal-title":"Eur J Neurol"},{"issue":"6","key":"2117_CR58","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.neurobiolaging.2007.09.002","volume":"30","author":"M O\u2019Sullivan","year":"2009","unstructured":"O\u2019Sullivan M, Ngo E, Viswanathan A, Jouvent E, Gschwendtner A, Saemann PG, et al. Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol Aging. 2009 Jun;30(6):890\u20137.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"2117_CR59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/hipo.22690","volume":"27","author":"CM Fiford","year":"2017","unstructured":"Fiford CM, Manning EN, Bartlett JW, Cash DM, Malone IB, Ridgway GR, et al. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy. Hippocampus. 2017;27(3):249\u201362.","journal-title":"Hippocampus."},{"issue":"5","key":"2117_CR60","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1747-4949.2011.00666.x","volume":"6","author":"TB Cumming","year":"2011","unstructured":"Cumming TB, Brodtmann A. Can stroke cause neurodegenerative dementia? Int J Stroke. 2011;6(5):416\u201324.","journal-title":"Int J Stroke"},{"issue":"4","key":"2117_CR61","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/ijs.12466","volume":"10","author":"PM Bath","year":"2015","unstructured":"Bath PM, Wardlaw JM. Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. Int J Stroke. 2015;10(4):469\u201378.","journal-title":"Int J Stroke"},{"issue":"11","key":"2117_CR62","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1161\/CIRCULATIONAHA.104.501163","volume":"112","author":"D Carole","year":"2005","unstructured":"Carole D, John C, Oguzhan C, V\u00e9ronique B, Marie-Germaine B, Pierre G, et al. Effects of blood pressure lowering on cerebral white matter Hyperintensities in patients with stroke. Circulation. 2005;112(11):1644\u201350.","journal-title":"Circulation."},{"key":"2117_CR63","doi-asserted-by":"crossref","unstructured":"Kuv\u00e5s KR, Saltvedt I, Aam S, Thingstad P, Ellekj\u00e6r H, Askim T. <p>The Risk of Selection Bias in a Clinical Multi-Center Cohort Study. Results from the Norwegian Cognitive Impairment After Stroke (Nor-COAST) Study<\/p> [Internet]. Vol. 12, Clinical Epidemiology. Dove Press; 2020 [cited 2021 Jan 19]. p. 1327\u201336. Available from: https:\/\/www.dovepress.com\/the-risk-of-selection-bias-in-a-clinical-multi-center-cohort-study-res-peer-reviewed-fulltext-article-CLEP","DOI":"10.2147\/CLEP.S276631"},{"key":"2117_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.00699","volume":"11","author":"S Aam","year":"2020","unstructured":"Aam S, Einstad MS, Munthe-Kaas R, Lydersen S, Ihle-Hansen H, Knapskog A-B, et al. Post-stroke Cognitive Impairment\u2014Impact of Follow-Up Time and Stroke Subtype on Severity and Cognitive Profile: The Nor-COAST Study. Front Neurol. 2020;11:1 [cited 2021 Jan 17]. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.00699\/full?utm_source=F-AAE&utm_medium=EMLF&utm_campaign=MRK_1389472_54_Neurol_20200728_arts_A.","journal-title":"Front Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02117-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-021-02117-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02117-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T22:57:27Z","timestamp":1697929047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02117-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02117-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"11 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the regional committee for medical and health research, REK Nord (REK number: 2015\/171 & 2016\/2306).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IS was investigator in the drug trial Boehringer-Ingelheim 1346.0023.The other authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}